Off-label baclofen prescribing practices among French alcohol specialists: Results of a national online survey

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Rolland, Benjamin ^a,b   Paille, François ^a,c   Fleury, Benoit ^a,d   Cottencin, Olivier ^a,b   Benyamina, Amine ^a,e   Aubin, Henri Jean ^a,e  

^a Société Française d Alcoologie   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

ADULT; ALCOHOL USE DISORDER; ARTICLE; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL SPECIALIST; OFF LABEL DRUG USE; PHYSICIAN ATTITUDE; ALCOHOLISM; CLINICAL PRACTICE; DOSE RESPONSE; INFORMATION PROCESSING; INTERNET; PRESCRIPTION; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ALCOHOLISM; BACLOFEN; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PRESCRIPTIONS; FRANCE; HUMANS; INTERNET; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 84902349989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098062     Document Type: Article

References (30)

1. Sachais BA, Logue JN, Carey MS (1977) Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis. Arch Neurol 34: 422-8. (Pubitemid 8141201)
2. Gorsane M-A, Kebir O, Hache G, Blecha L, Aubin H-J, et al. (2012) Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Subst Abuse 33: 336-49.
3. Agabio R, Preti A, Gessa GL (2013) Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review. Eur Addict Res 19: 325-45.
4. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37: 504-8.
5. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, et al. (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370: 1915-22. (Pubitemid 350192657)
6. Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 34: 1849-57.
7. Ameisen O (2005) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol 40: 147-50.
8. Bucknam W (2007) Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol 42: 158-60.
9. Pastor A, Jones DML, Currie J (2012) High-dose baclofen for treatment-resistant alcohol dependence. J Clin Psychopharmacol 2012;32: 266-8.
10. Beaurepaire R de (2012) Suppression of alcohol dependence using baclofen: a 2-year observational study of 100 patients. Front Psychiatry 3: 103.
11. Rigal L, Alexandre-Dubroeucq C, de Beaurepaire R, Le Jeunne C, Jaury P (2012) Abstinence and "Low-Risk" Consumption 1 Year after the Initiation of High-Dose Baclofen: A Retrospective Study among "High-Risk" Drinkers. Alcohol Alcohol 47(4): 439-42.
12. Ameisen O (2008) Le Dernier Verre. Denoël.
13. Enserink M (2011) Addiction research. Anonymous alcoholic bankrolls trial of controversial therapy. Science 332: 653.
14. Rolland B, Bordet R, Cottencin O (2012) Alcohol-dependence: the current French craze for baclofen. Addiction 107: 848-9.
15. Franchitto N, Pelissier F, Lauque D, Simon N, Lançon C (2014) Self-Intoxication with Baclofen in Alcohol-Dependent Patients with Co-existing Psychiatric Illness: An Emergency Department Case Series. Alcohol Alcohol 49(1): 79-83.
16. Villier C, Schir E, Mallaret M (2011) Effets indésirables du baclofène dans le traitement des addictions: suivi national de Pharmacovigilance 2012. [Adverse drug reactions of baclofen in the treatment of addictions: national pharmacovigilance 2012 follow-up]. Comitétechnique de pharmacovigilance. Available: http://ansm.sante.fr/content/download/41100/ 535097/version/2/file/baclofene-suivi-pharmacovigilance-2011.pdf. (Accessed 30 April 2014).
17. Rolland B, Deheul S, Danel T, Bordet R, Cottencin O (2010) A System of Prescriptions without Drug Approval: Example of Baclofen. Therapie 65: 511-8.
18. Emmerich J, Dumarcet N, Lorence A (2012) France's New Framework for Regulating Off-Label Drug Use. N Engl J Med 367: 1279-81.
19. Luquiens A, Reynaud M, Aubin HJ (2011) Is controlled drinking an acceptable goal in the treatment of alcohol dependence? A survey of French alcohol specialists. Alcohol Alcohol 46(5): 586-91.
20. Rolland B, Deheul S, Danel T, Bordet R, Cottencin O (2012) A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol. Alcohol Alcohol 47(5): 577-80.
21. Bence C, Cottencin O, Deheul S, Gautier S, Bordet R, et al. (2014) Baclofen-induced edema in alcohol use disorders. J Clin Pharmacol 54(4): 478-81.
22. Rolland B, Jaillette E, Carton L, Bence C, Deheul S, et al. (2014) Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder. J Clin Psychopharmacol 34(1): 153-6.
23. Auffret M, Rolland B, Deheul S, Loche V, Hennaux C, et al. (2014) Severe Tinnitus Induced by Off-Label Baclofen. Ann Pharmacother 48(5): 656-9.
24. Geoffroy PA, Auffret M, Deheul S, Bordet R, Cottencin O, et al. (2014) Baclofen-Induced Manic Symptoms: Case Report And Systematic Review. Psychosomatics doi.org/10.1016/j.psym.2014.02.003.
25. Dal Pan GJ (2012) Monitoring the safety of medicines used off-label. Clin Pharmacol Ther 91: 787-95.
26. Burns KEA, Duffett M, Kho ME, Meade MO, Adhikari NKJ, et al. (2008) A guide for the design and conduct of self-administered surveys of clinicians. CMAJ 179: 245-52.
27. Dupouy J, Fournier JP, Jouanjus E, Palmaro A, Poutrain JC, et al.(2014) Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns-A cohort study. Eur Neuropsychopharmacol 24(2): 192-9.
28. Bennett C, Khangura S, Brehaut JC, Graham ID, Moher D, et al. (2010) Reporting guidelines for survey research: an analysis of published guidance and reporting practices. PLoS Med 8: e1001069.
29. Dom G (2012) Why Belgian alcohol patients are treated differently than their French counterparts. Acta Clin Belg 67(5): 315-6.
30. Gache P. (2011) [Baclofen: the new miracle cure for alcoholism?] Rev Med Suisse 2011; 7(302): 1458-61.